Skip to content
Home/Companies/MedTech/Tissuemed
TI

Tissuemed

MedTech·UK·Exited 2021·Held 7yr

Tissuemed is a MedTech company, headquartered in UK.

Entry
2014
Hold
7yr
Exit
2021
Est. EV
–

Who owns Tissuemed?

Tissuemed was owned by Shackleton Ventures through Shackleton Ventures (Evergreen) (2006 vintage) from 2014 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-30

Shackleton Ventures
Investor
Shackleton Ventures
Shackleton Ventures (Evergreen) · 2006 · Evergreen

Key facts

HQUK
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from Shackleton Ventures (Evergreen)

Other portfolio companies in the same fund.

Ioniq Group
Active
FinancialsGermany· 2024
Alusid
Active
IndustrialsUK· 2023
Omnigen
Active
HealthTechUK· 2023
Varamis Rail
Active
LogisticsUK· 2023
Advanced Electric Machines
Active
IndustrialsUK· 2022
Eventum Orthopaedics
Active
MedTechUK· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Custom Surgical
Active
ZEISS VenturesGermany· 2026
Data refreshed weekly · Sourced from public filings